Roche

Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive
Fri, 07/12/24 - 11:29 am
Eisai
Biogen
Leqembi
Alzheimer's disease
Roche
Spark Therapeutics
gene therapy
layoffs
Roche to reintroduce eye implant med Susvimo 2 years after recall
Fierce Pharma
Mon, 07/8/24 - 11:06 pm
Roche
Susvimo
FDA
wet age-related macular degeneration
Roche scores FDA nod for prefilled syringe version of Vabysmo, easing its administration
Fierce Pharma
Mon, 07/8/24 - 11:47 am
Roche
Vabysmo
FDA
Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo
BioSpace
Mon, 07/8/24 - 11:41 am
Roche
clinical trials
tiragolumab
non-small cell lung cancer
Supreme Court gives pharma giants another chance to sidestep terrorism-funding case
Fierce Pharma
Mon, 06/24/24 - 10:08 pm
legal
AstraZeneca
GE Healthcare
JNJ
Pfizer
Roche
terrorism
Novo Nordisk unwraps phase 3 hemophilia A data, revealing how Roche rivalry may shake out
Fierce Biotech
Mon, 06/24/24 - 10:54 am
Novo Nordisk
Mim8
hemophilia A
clinical trials
Roche
Hemlibra
How Roche is finding better ways to diagnose brain conditions like Alzheimer’s and Parkinson’s disease
Pharma Voice
Tue, 06/18/24 - 11:34 am
Roche
biomarkers
Alzheimer's disease
Parkinson's Disease
R&D
Roche partners with RNA editing biotech Ascidian
BioPharma Dive
Tue, 06/18/24 - 11:31 am
Roche
Ascidian Therapeutics
RNA exon editing
drug development
neurology
Roche's Columvi win in earlier DLBCL faces questions over inconsistent patient survival data
Fierce Pharma
Sun, 06/16/24 - 08:57 pm
Roche
Columvi
diffuse large B-cell lymphoma
clinical trials
Roche’s spinal muscular atrophy treatment Evrysdi shows continued benefit in children
PM Live
Fri, 06/14/24 - 11:38 am
Roche
SMA
Evrysdi
clinical trials
Roche’s Evrysdi offers sustained benefits in SMA extension trial in children
Clinical Trials Arena
Mon, 06/10/24 - 11:06 am
Roche
clinical trials
Evrysdi
SMA
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters
Thu, 06/6/24 - 11:34 am
Novartis
Roche
Genentech
Italy
antitrust
Biogen
Samsung Bioepis
Byooviz
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
R&D
Novartis
Argo Biopharmaceutical
Roche
MOMA Therapeutics
Boehringer Ingelheim
Suzhou Ribo Life Science
Eli Lilly
Isomorphic Labs
Merus
Gilead Sciences
Novo Nordisk
Neomorph
AbbVie
Umoja Biopharma
Merck KGaA
Caris Life Sciences
Voyager Therapeutics
Roche seeking to revamp pharma inventory management
Biopharma Reporter
Thu, 05/30/24 - 11:05 am
Roche
inventory
crowdsourcing
Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candidate
BioSpace
Thu, 05/16/24 - 11:40 am
Roche
Genentech
CT-388
Carmot
weight loss
clinical trials
New name takes top spot in reputation ranking by US patient groups
Fierce Pharma
Tue, 05/14/24 - 11:14 pm
patient groups
reputation
Servier
Roche
ViiV
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline
Fierce Biotech
Mon, 05/13/24 - 11:25 am
Sanofi
Fulcrum Therapeutics
Roche
GSK
Rare Diseases
clinical trials
losmapimod
As Autism Cases Rise, Biopharma Springs Into Action
BioSpace
Mon, 04/29/24 - 11:10 am
autism
asd
Roche
Curemark
Yamo Pharmaceuticals
Marvel Biosciences
R&D
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
obesity
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
Roche
AstraZeneca

Pages